• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Molecular Diagnostics Market

Molecular Diagnostics Market Study and Trend Research 2014-2025


Covid-19

COVID-19

Understand the influence of COVID-19 on the Molecular Diagnostics Market with our analysts monitoring the situation across the globe.
REPORT HIGHLIGHT

The molecular diagnostics market is estimated to represent a global market of USD 5,933 million by 2017 with growth rate of 9.1%.

The molecular diagnostic, a subset of in vitro diagnostics, is a laboratory technique, used to identify the underlying cause of disease condition. It offers a rapid approach for the detection of a wide range of human ailments. Demand for molecular diagnostics is growing at a rapid pace across the globe. This diagnostic test enables to detect specific sequences in genetic material i.e. DNA or RNA associated with the specific disease condition. The diagnosis helps the physician to uncover underlying mechanism of the disease condition. This technique requires easy steps, including, extraction and purification, amplification, and detection of the amplified target using PCR technique. The molecular diagnostic test is a dynamic area of diagnostic technique which has recolonized healthcare industry.

Market Dynamics

Currently, molecular diagnostics captured relatively a small share of the overall diagnostic industry. However, this technique has captured significant attention among scientists as it plays important role in the field of pharmaceutical and biotechnology industries. Nowadays, this technique is routinely used in reference laboratories, hospitals, and blood banks. Continuous innovation in the field of diagnostics is expected to stimulate the development of molecular diagnostics area at rapid pace. For example, increasing automation has enabled molecular tests to be performed at the full scope of healthcare settings.

This advancement has also paved the way for molecular diagnostics to detect various viruses and bacteria which are difficult to culture with traditional techniques. For example, tuberculosis bacillus bacteria can be detected effectively through molecular diagnostic method. Additionally, the emergence of cutting-edge molecular diagnostic technologies for cancer and infectious diseases further boosted the market growth considerably. For example, leading companies are increasingly researching on an application of DNA chip or microarray for a molecular test. This will allow detection of the multitude of pathogens at one point in time. Such advancements are projected to establish the healthy platform for the market growth, leading to driving the industry. However, a high cost of these tests is considered to be one of the major restraining factor. However, faster diagnostic results and more targeted treatment through these tests will reduce the hospitalization cost, decreasing overall healthcare cost.

Products Takeaway

In terms of products, the market is categorized as instruments and reagent. Among which, reagent segment captured the largest share of the total market. Development of new reagents for various diagnostic testing assays is expected to support the market growth to some extent. For example, Bioline offers the variety of molecular reagent for detection and monitoring of various disease condition. Company’s portfolio includes reagents such as  ISOLATE II Nucleic Acid Isolation Kits, SensiFAST Real-Time PCR Kits, JetSeq DNA Library Preparation Kit, and many others. Technology segment is divided as In Situ Hybridization, PCR, Mass spectrometry, Chips and microarrays, Sequencing, Transcription Mediated Amplification (TMA), and Others.

Application Takeaway

In terms of application, the market is bifurcated as Infectious Diseases, Blood Screening, Histology, Oncology, Prenatal, Pharmacogenomics, Coagulation, Tissue Typing, and Inherited Diseases. In 2017, infectious disease is the most dominant segment (captured around 52%) and is projected to grow significantly over the future period. The emergence of novel technologies such as point of care molecular assays for the detection of infectious diseases drives the segment growth to great extent. Location segment is categorized as Point of care, Self-test, and Central Laboratories.

Regional Takeaway

Regionally, North America accounted for the largest share owing to the rising research and development activities coupled with new product approvals. In Europe, presence of high prevalence rates of target diseases coupled with high healthcare expenditures in Western European countries support the industry growth. The growth of this market in developing regions is primarily driven by the rising access to the advanced healthcare facilities coupled with favorable government initiatives.

Key Vendor Takeaway

Companies such as Abbott, bioMérieux, Danaher Corporation, Qiagen, and Roche are profiled in the study. The industry is highly competitive and consolidated in nature, led by few number of key players, accounting for majority of revenue share. For example, Roche Diagnostics, with a market share of around 35%, is considered to be the leading player of the market. The market is witnessing a flurry of mergers & acquisitions among small scale and large scale industries. For example, Hologic acquired Gen-Probe in August, 2012, in an attempt to gain share via market expansion.	
TABLE OF CONTENT

1. MOLECULAR DIAGNOSTICS MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. MOLECULAR DIAGNOSTICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. MOLECULAR DIAGNOSTICS INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Regulatory Framework Analysis
4.3. Market Attractiveness Analysis
4.4. Value Chain Analysis
5. MOLECULAR DIAGNOSTICS MARKET LANDSCAPE 
5.1. Market Share Analysis
6. MOLECULAR DIAGNOSTICS MARKET – BY PRODUCTS:
6.1. Overview
6.2. Instruments
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Reagent
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. MOLECULAR DIAGNOSTICS MARKET – BY PRODUCTS:
7.1. Overview
7.2. Point of care
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Self-test
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Central Laboratories
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. MOLECULAR DIAGNOSTICS MARKET – BY PRODUCTS:
8.1. Overview
8.2. Infectious Diseases
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Blood Screening
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Histology
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Oncology
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.6. Prenatal
8.6.1. Overview
8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.7. Pharmacogenomics
8.7.1. Overview
8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.8. Coagulation
8.8.1. Overview
8.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.9. Tissue Typing
8.9.1. Overview
8.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. MOLECULAR DIAGNOSTICS MARKET– BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.2.3. U.S.
9.2.3.1. Overview
9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.2.4. Canada
9.2.4.1. Overview
9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.3. France
9.3.3.1. Overview
9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.4. Germany
9.3.4.1. Overview
9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.5. Rest of Europe
9.3.5.1. Overview
9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4.3. China
9.4.3.1. Overview
9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4.4. India
9.4.4.1. Overview
9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4.5. Rest of APAC
9.4.5.1. Overview
9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5. Rest of the World
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5.3. Latin America
9.5.3.1. Overview
9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5.4. Middle East and Africa
9.5.4.1. Overview
9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. Abbott
10.1.1. Company Overview
10.1.2. SWOT Analysis
10.1.3. Key Developments
10.2. bioMérieux
10.2.1. Company Overview
10.2.2. SWOT Analysis
10.2.3. Key Developments
10.3. Danaher Corporation
10.3.1. Company Overview
10.3.2. SWOT Analysis
10.3.3. Key Developments
10.4. Qiagen
10.4.1. Company Overview
10.4.2. SWOT Analysis
10.4.3. Key Developments
10.5. Roche
10.5.1. Company Overview
10.5.2. SWOT Analysis
10.5.3. Key Developments
*Client can request additional company profiling as per specific requirements
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. Abbreviations
12.3. Disclaimer
12.4. Contact Us

	List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Molecular Diangostics Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Table 10 Molecular Diangostics Market, by Products, 2014 – 2025 (USD Million)
Table 11 Molecular Diangostics Market, by Location, 2014 – 2025 (USD Million)
Table 12 Molecular Diangostics Market, by Application, 2014 – 2025 (USD Million)
Table 13 Molecular Diangostics Market, by Geography, 2014 – 2025 (USD Million)
Table 14 North America Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 15 U.S. Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 16 Canada Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 17 Europe Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 18 France Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 19 Germany Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 20 Asia Pacific Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 21 China Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 22 India Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 23 Latin America Molecular Diangostics Market, 2014 – 2025 (USD Million)
Table 24 MEA Molecular Diangostics Market, 2014 – 2025 (USD Million) List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Molecular Diangostics Market, by Products, 2014 – 2025 (USD Million)
Figure 7 Molecular Diangostics Market, by Location, 2014 – 2025 (USD Million)
Figure 8 Molecular Diangostics Market, by Application, 2014 – 2025 (USD Million)
Figure 9 Molecular Diangostics Market, by Geography, 2014 – 2025 (USD Million)

Related Reports

Orthopedic-Care-Products-Market

Global Orthopedic Care Products Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Orthopedic Care Products market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Orthopedic Care Products marke ...read more

Oral-and-Dental-Probiotics-Market

Global Oral & Dental Probiotics Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Oral & Dental Probiotics market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Oral & Dental Probiotics marke ...read more

Magnesium-Supplements-Market

Global Magnesium Supplements Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Magnesium Supplements market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Magnesium Supplements market repo ...read more

Bioactive-Peptides-Market

Global Bioactive Peptides Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Bioactive Peptides market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Bioactive Peptides market report is ...read more

Vaccine-Market

Global Vaccine Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Vaccine market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Vaccine market report is a comprehensive resear ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.